Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2012, Article ID 560493, 10 pages
http://dx.doi.org/10.1155/2012/560493
Review Article

Investigational Paradigms in Downscoring and Upscoring DCIS: Surgical Management Review

Division of Surgical Oncology, Department of Surgery, Tor Vergata University Hospital, 00133 Rome, Italy

Received 12 January 2012; Accepted 14 March 2012

Academic Editor: Kimberly Van Zee

Copyright © 2012 P. Orsaria et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Silverstein, D. N. Poller, J. R. Waisman et al., “Prognostic classification of breast ductal carcinoma-in-situ,” The Lancet, vol. 345, no. 8958, pp. 1154–1157, 1995. View at Google Scholar · View at Scopus
  2. H. Buerger, F. Otterbach, R. Simon et al., “Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways,” The Journal of Pathology, vol. 187, no. 4, pp. 396–402, 1999. View at Publisher · View at Google Scholar
  3. B. A. Virnig, T. M. Tuttle, T. Shamliyan, and R. L. Kane, “Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes,” Journal of the National Cancer Institute, vol. 102, no. 3, pp. 170–178, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. E. Sanders, P. A. Schuyler, W. D. Dupont, and D. L. Page, “The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up,” Cancer, vol. 103, no. 12, pp. 2481–2484, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. G. D. Leonard and S. M. Swain, “Ductal carcinoma in situ, complexities and challenges,” Journal of the National Cancer Institute, vol. 96, no. 12, pp. 906–920, 2004. View at Google Scholar · View at Scopus
  6. V. L. Ernster, R. Ballard-Barbash, W. E. Barlow et al., “Detection of ductal carcinoma in situ in women undergoing screening mammography,” Journal of the National Cancer Institute, vol. 94, no. 20, pp. 1546–1554, 2002. View at Google Scholar · View at Scopus
  7. K. Kerlikowske, “Epidemiology of ductal carcinoma in situ,” Journal of the National Cancer Institute. Monographs, vol. 2010, no. 41, pp. 139–141, 2010. View at Google Scholar · View at Scopus
  8. C. I. Li, J. R. Daling, and K. E. Malone, “Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 4, pp. 1008–1011, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Rosai, “Borderline epithelial lesions of the breast,” American Journal of Surgical Pathology, vol. 15, no. 3, pp. 209–221, 1991. View at Google Scholar · View at Scopus
  10. F. A. Tavassoli, “Breast pathology: rationale for adopting the ductal intraepithelial neoplasia (DIN) classification,” Nature Clinical Practice Oncology, vol. 2, no. 3, pp. 116–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Holland, J. L. Peterse, R. R. Millis et al., “Ductal carcinoma in situ: a proposal for a new classification,” Seminars in Diagnostic Pathology, vol. 11, no. 3, pp. 167–180, 1994. View at Google Scholar
  12. E. Rakovitch, A. Mihai, J. P. Pignol et al., “Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ?” Breast Cancer Research and Treatment, vol. 87, no. 3, pp. 265–272, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. F. A. Tavassoli, “Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia,” Modern Pathology, vol. 11, no. 2, pp. 140–154, 1998. View at Google Scholar · View at Scopus
  14. P. O'Connell, V. Pekkel, S. A. W. Fuqua, C. K. Osborne, G. M. Clark, and D. C. Allred, “Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci,” Journal of the National Cancer Institute, vol. 90, no. 9, pp. 697–703, 1998. View at Google Scholar · View at Scopus
  15. G. L. Ottesen, H. P. Graversen, M. Blichert-Toft, I. J. Christensen, and J. A. Andersen, “Carcinoma in situ of the female breast. 10 Year follow-up results of a prospective nationwide study,” Breast Cancer Research and Treatment, vol. 62, no. 3, pp. 197–210, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Cutuli, C. Cohen-Solal-le Nir, B. de Lafontan et al., “Breast-conserving therapy for ductal carcinoma in situ of the breast: The French Cancer Centers' experience,” International Journal of Radiation Oncology Biology Physics, vol. 53, no. 4, pp. 868–879, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. A. C. Neuschatz, T. DiPetrillo, M. Steinhoff et al., “The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast,” Cancer, vol. 94, no. 7, pp. 1917–1924, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Dunne, J. P. Burke, M. Morrow, and M. R. Kell, “Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ,” Journal of Clinical Oncology, vol. 27, no. 10, pp. 1615–1620, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. J. Silverstein, J. R. Waisman, P. Gamagami et al., “Intraductal carcinoma of the breast (208 cases). Clinical factors influencing treatment choice,” Cancer, vol. 66, no. 1, pp. 102–108, 1990. View at Google Scholar
  20. C. O. C. Bellamy, C. McDonald, D. M. Salter, U. Chetty, and T. J. Anderson, “Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization,” Human Pathology, vol. 24, no. 1, pp. 16–23, 1993. View at Publisher · View at Google Scholar · View at Scopus
  21. G. F. Schwartz, G. C. Finkel, J. C. Garcia, and A. S. Patchefsky, “Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone,” Cancer, vol. 70, no. 10, pp. 2468–2474, 1992. View at Google Scholar
  22. M. D. Lagios, F. R. Margolin, P. R. Westdahl, and M. R. Rose, “Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence,” Cancer, vol. 63, no. 4, pp. 618–624, 1989. View at Google Scholar · View at Scopus
  23. M. D. Lagios, “Ductal carcinoma in situ: controversies in diagnosis, biology, and treatment,” The Breast Journal, vol. 1, no. 2, pp. 68–78, 1995. View at Publisher · View at Google Scholar
  24. M. J. Silverstein and C. Buchanan, “Ductal carcinoma in situ: USC/Van Nuys prognostic index and the impact of margins status,” Breast, vol. 12, no. 6, pp. 457–471, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. M. J. Silverstein, “The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast,” The American Journal of Surgery, vol. 186, no. 4, pp. 337–343, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Morrow, E. A. Strom, L. W. Bassett et al., “Standard for the management of ductal carcinoma in situ of the breast (DCIS),” Ca-A Cancer Journal for Clinicians, vol. 52, no. 5, pp. 256–276, 2002. View at Google Scholar · View at Scopus
  27. N. Patani, Y. Khaled, S. Al Reefy, and K. Mokbel, “Ductal carcinoma in situ: an update for clinical practice,” Surgical Oncology, vol. 20, no. 1, pp. e23–e31, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Douek and M. Baum, “Mass breast screening: is there a hidden cost?” British Journal of Surgery, vol. 90, pp. 44–45, 2003. View at Google Scholar
  29. B. Cutuli, C. Lemanski, A. Fourquet et al., “Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience,” British Journal of Cancer, vol. 100, no. 7, pp. 1048–1054, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. L. A. Newman, “Local control of ductal carcinoma in situ based on tumor and patient characteristics: the surgeon's perspective,” Journal of the National Cancer Institute. Monographs, vol. 2010, no. 41, pp. 152–157, 2010. View at Google Scholar · View at Scopus
  31. S. di Saverio, F. Catena, D. Santini et al., “259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up,” Breast Cancer Research and Treatment, vol. 109, no. 3, pp. 405–416, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Cutuli, C. Cohen-Solal-Le Nir, B. de Lafontan et al., “Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients,” European Journal of Cancer, vol. 37, no. 18, pp. 2365–2372, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. G. H. Cunnick and K. Mokbel, “Skin-sparing mastectomy,” The American Journal of Surgery, vol. 188, no. 1, pp. 78–84, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. G. W. Carlson, A. Page, E. Johnson, K. Nicholson, T. M. Styblo, and W. C. Wood, “Local recurrence of ductal carcinoma in situ after skin-sparing mastectomy,” Journal of the American College of Surgeons, vol. 204, no. 5, pp. 1074–1078, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. D. R. G. Faverly, L. Burgers, P. Bult et al., “Three dimensional imaging of mammary ductal carcinoma in situ; clinical implications,” Seminars in Diagnostic Pathology, vol. 11, no. 3, pp. 193–198, 1994. View at Google Scholar
  36. P. I. Tartter, J. Kaplan, I. Bleiweiss et al., “Lumpectomy margins, reexcision, and local recurrence of breast cancer,” The American Journal of Surgery, vol. 179, no. 2, pp. 81–85, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Aziz, E. Rawlinson, S. A. Narod et al., “The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer,” The Breast Journal, vol. 12, no. 4, pp. 331–337, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Edge, R. Ottesen, and E. Lepisto, “Surgical biopsy to diagnose breast cancer adversely affects outcomes of breast cancer care: finding from the National Comprehensive Cancer Network,” in Proceedings of the San Antonio Breast Cancer Symposium, American Association for Cancer Research, San Antonio, Tex, USA, 2005, Abstract 12.
  39. B. Cutuli, C. Lemanski, and M. le Blanc, “Local recurrences after DCIS therapy: diagnosis, treatment and outcome,” Breast Cancer Research and Treatment, vol. 76, supplement 1, article S36, 2002, Abs 31. View at Google Scholar
  40. L. J. Solin, A. Fourquet, F. A. Vicini et al., “Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ,” European Journal of Cancer, vol. 41, no. 12, pp. 1715–1723, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. M. J. Silverstein, M. D. Lagios, S. Martino et al., “Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast,” Journal of Clinical Oncology, vol. 16, no. 4, pp. 1367–1373, 1998. View at Google Scholar · View at Scopus
  42. A. Ringberg, I. Idvall, M. Ferno et al., “Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast,” European Journal of Surgical Oncology, vol. 26, no. 5, pp. 444–451, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. H. R. MacDonald, M. J. Silverstein, H. Mabry et al., “Local control in ductal carcinoma in situ treated by excision alone: Incremental benefit of larger margins,” The American Journal of Surgery, vol. 190, no. 4, pp. 521–525, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. M. J. Silverstein, E. D. Gierson, W. J. Colburn et al., “Can intraductal breast carcinoma be excised completely by local excision,” Cancer, vol. 73, no. 12, pp. 2985–2989, 1994. View at Google Scholar
  45. M. J. Silverstein, M. D. Lagios, P. H. Craig et al., “A prognostic index for ductal carcinoma in situ of the breast,” Cancer, vol. 77, no. 11, pp. 2267–2274, 1996. View at Google Scholar
  46. M. D. Lagios and M. J. Silverstein, “Ductal carcinoma in situ: the success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies,” Surgical Oncology Clinics of North America, vol. 6, no. 2, pp. 385–392, 1997. View at Google Scholar · View at Scopus
  47. A. Recht, “Side effects of radiation therapy,” in Ductal Carcinoma In Situ of the Breast, M. J. Silverstein, Ed., p. 347, Williams & Wilkins, Baltimore, Md, USA, 1997. View at Google Scholar
  48. M. J. Silverstein, M. D. Lagios, S. Groshen et al., “The influence of margin width on local control of ductal carcinoma in situ of the breast,” New England Journal of Medicine, vol. 340, no. 19, pp. 1455–1461, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. X. J. Ma, R. Salunga, J. T. Tuggle et al., “Gene expression profiles of human breast cancer progression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 10, pp. 5974–5979, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. D. C. Allred, Y. Wu, S. Mao et al., “Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution,” Clinical Cancer Research, vol. 14, no. 2, pp. 370–378, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. U. Rudloff, L. M. Jacks, J. I. Goldberg et al., “Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ,” Journal of Clinical Oncology, vol. 28, no. 23, pp. 3762–3769, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. C. E. Cox and J. W. Jakub, “Re: importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?” American Surgeon, vol. 68, no. 5, pp. 500–502, 2002. View at Google Scholar · View at Scopus
  53. C. H. Lee, D. Carter, L. E. Philpotts et al., “Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted?” Radiology, vol. 217, no. 2, pp. 466–470, 2000. View at Google Scholar · View at Scopus
  54. H. Mabry, A. E. Giuliano, and M. J. Silverstein, “What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?” The American Journal of Surgery, vol. 192, no. 4, pp. 455–457, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. O. C. Buonomo, P. Orsaria, G. Contino et al., “Pathological classification of DCIS and planning of therapeutic management,” Anticancer Research, vol. 29, no. 5, pp. 1499–1506, 2009. View at Google Scholar · View at Scopus
  56. S. A. Silver and F. A. Tavassoli, “Mammary ductal carcinoma in situ with microinvasion,” Cancer, vol. 77, no. 11, pp. 2267–2274, 1996. View at Google Scholar
  57. K. Kerlikowske, A. Molinaro, I. Cha, B. M. Ljung et al., “Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy,” Journal of the National Cancer Institute, vol. 95, no. 22, pp. 1692–1702, 2003. View at Google Scholar
  58. B. Fisher, S. Land, E. Mamounas, J. Dignam, E. R. Fisher, and N. Wolmark, “Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience,” Seminars in Oncology, vol. 28, no. 4, pp. 400–418, 2001. View at Google Scholar
  59. N. Bijker, J. L. Peterse, L. Duchateau et al., “Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853,” Journal of Clinical Oncology, vol. 19, no. 8, pp. 2263–2271, 2001. View at Google Scholar · View at Scopus
  60. J. Houghton, W. D. George, J. Cuzick et al., “Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial,” Lancet, vol. 362, no. 9378, pp. 95–102, 2003. View at Publisher · View at Google Scholar
  61. J. L. Warren, D. L. Weaver, T. Bocklage et al., “The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis,” Cancer, vol. 104, no. 9, pp. 1840–1848, 2005. View at Google Scholar
  62. B. M. Sabin , G. Sharad, S. M. Meena et al., “Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194,” Cancer, vol. 117, no. 6, pp. 1156–1162, 2011. View at Google Scholar